DK1450771T3 - Farmaceutiske præparater til behandling af hudlæsioner og slimhinder og fremgangsmåder og kits til anvendelse heraf - Google Patents

Farmaceutiske præparater til behandling af hudlæsioner og slimhinder og fremgangsmåder og kits til anvendelse heraf

Info

Publication number
DK1450771T3
DK1450771T3 DK02775182T DK02775182T DK1450771T3 DK 1450771 T3 DK1450771 T3 DK 1450771T3 DK 02775182 T DK02775182 T DK 02775182T DK 02775182 T DK02775182 T DK 02775182T DK 1450771 T3 DK1450771 T3 DK 1450771T3
Authority
DK
Denmark
Prior art keywords
kits
methods
pharmaceutical compositions
mucous membranes
skin lesions
Prior art date
Application number
DK02775182T
Other languages
English (en)
Inventor
Pinchas Burstein
Original Assignee
Innovative Pharmaceutical Conc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Pharmaceutical Conc filed Critical Innovative Pharmaceutical Conc
Application granted granted Critical
Publication of DK1450771T3 publication Critical patent/DK1450771T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02775182T 2001-10-03 2002-10-02 Farmaceutiske præparater til behandling af hudlæsioner og slimhinder og fremgangsmåder og kits til anvendelse heraf DK1450771T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/968,771 US7128903B2 (en) 2001-10-03 2001-10-03 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
PCT/IL2002/000804 WO2003028623A2 (en) 2001-10-03 2002-10-02 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucuous membranes

Publications (1)

Publication Number Publication Date
DK1450771T3 true DK1450771T3 (da) 2008-10-06

Family

ID=25514753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02775182T DK1450771T3 (da) 2001-10-03 2002-10-02 Farmaceutiske præparater til behandling af hudlæsioner og slimhinder og fremgangsmåder og kits til anvendelse heraf

Country Status (9)

Country Link
US (3) US7128903B2 (da)
EP (1) EP1450771B1 (da)
AT (1) ATE399002T1 (da)
AU (1) AU2002341366A1 (da)
DE (1) DE60227278D1 (da)
DK (1) DK1450771T3 (da)
ES (1) ES2309205T3 (da)
IL (1) IL161177A0 (da)
WO (1) WO2003028623A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128903B2 (en) 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20050020693A1 (en) * 2003-07-24 2005-01-27 Richard Strauss Pharmaceutical preparations useful as drying agents and for treatment of warts
AU2004200891B2 (en) * 2004-03-01 2010-10-14 Universal Entertainment Corporation Gaming machine
GB0426308D0 (en) * 2004-12-01 2004-12-29 Byotrol Llc Preservative and embalming fluids
SE527996C2 (sv) * 2004-12-21 2006-08-01 Tagaway Devices Aps Anordning för avlägsnande av acrochordons
US8357720B2 (en) * 2005-03-23 2013-01-22 Florida Atlantic University Treatment or prevention of cancer and precancerous disorders
WO2006102439A2 (en) * 2005-03-23 2006-09-28 Florida Atlantic University Treatment or prevention of cancer and precancerous disorders
US8765808B2 (en) * 2005-03-23 2014-07-01 Chs Pharma, Inc. Treatment or prevention of cancer and precancerous disorders
ITRM20060289A1 (it) * 2006-05-31 2007-12-01 Ranieri Cancedda Bio membrana ingegnerizzata osteo angiogenica e suoi usi per la rigenerazione di tessuto osseo
CN101138568A (zh) * 2006-09-08 2008-03-12 刘智仁 盐酸在制备治疗糖尿病和***疾病药物中的应用
US20080161782A1 (en) * 2006-10-26 2008-07-03 Reliant Technologies, Inc. Micropore delivery of active substances
US20090269390A1 (en) * 2008-04-25 2009-10-29 Medtronic, Inc. Medical devices, polymers, compositions, and methods for delivering a haloacetate
CA2736884A1 (en) 2008-09-17 2010-03-25 Patrick D. Mcgrath Antimicrobial sucralfate paste methods and compositions
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US20110218552A1 (en) * 2010-03-04 2011-09-08 Hoffman Roger P System and method of removing skin lesions
RU2482856C2 (ru) 2011-08-05 2013-05-27 Общество С Ограниченной Ответственностью "Оксигон" Комплексное соединение 2-хлорпропионата цинка и 2-хлорпропионовой кислоты, фармацевтическая композиция для лечения заболеваний кожи, способ ее получения и способ лечения поражений кожи, ногтей и видимых слизистых
WO2014045277A1 (en) * 2012-09-19 2014-03-27 Innovative Pharmaceuticalconcepts (Ipc) Inc. Medical applicator
US9987235B2 (en) * 2013-08-01 2018-06-05 Nicholas L. Abbott Methods and compositions for modifying mucous membranes
US10588564B2 (en) * 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
NL2014370B1 (nl) 2015-02-27 2017-01-17 Versailles B V Inrichting en werkwijze voor het aanbrengen van een samenstelling aan de huid of huidlagen.
ES2769673A1 (es) * 2018-12-20 2020-06-26 Philippe Deprez Composición a base de fenol y sus usos

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195095A (en) * 1969-04-04 1980-03-25 Sheffner Aaron L Topical application of thioglycolic acid in the treatment of dermatological conditions
US3924623A (en) * 1974-11-04 1975-12-09 Marion Health And Safety Inc Tip for applicator swab
CH629100A5 (de) 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
DE3035069C1 (de) * 1980-09-17 1982-05-27 Zyma Gmbh Saures dermatologisches Praeparat
US4588590A (en) * 1981-12-21 1986-05-13 Jaye-Boern Laboratories, Inc. Method of treating keratosis and compositions useful therefor
US5547988B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US5166176A (en) * 1986-12-29 1992-11-24 Obagi Zein E Composition for healing damaged skin
US5276032A (en) * 1989-12-28 1994-01-04 King O Newton Vision aid and anesthetic composition
US5322856A (en) * 1990-01-22 1994-06-21 Howard Martin Fortified glutaraldehyde chemical sterilant/disinfectant
TW210287B (da) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
EP0627879A1 (en) * 1991-09-20 1994-12-14 CAMIENER, Gerald, W. Methods and compositions with aldehyde stabilizing solution
MY128187A (en) 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
JP3595012B2 (ja) 1995-02-07 2004-12-02 第一製網株式会社 養殖海苔の赤腐れ病駆除剤
US5700656A (en) * 1995-05-25 1997-12-23 Pig Research Institute, Taiwan Silver stain for collagen matrix from paraffin embedded tissue
UY24246A1 (es) * 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
CN1059228C (zh) * 1995-10-11 2000-12-06 范暄民 消毒护肤洗手净
US5791801A (en) * 1996-08-30 1998-08-11 Siebe North, Inc. Liquid applicator
WO1998017247A1 (en) * 1996-10-23 1998-04-30 The Procter & Gamble Company Aqueous topical compositions comprising kojic acid, salicylic acid and a water soluble glycol ether
US6235474B1 (en) * 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
GB9807287D0 (en) * 1998-04-03 1998-06-03 Verdugt Bv Biocidal compositions
FR2782269B1 (fr) * 1998-08-17 2001-08-31 Oreal Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
US6573043B1 (en) * 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
SE513436C2 (sv) * 1999-01-21 2000-09-11 Astrid Agholme Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
FR2792642B1 (fr) * 1999-04-21 2001-06-08 Oreal Composition cosmetique contenant des particules de resine de melamine-formaldehyde ou d'uree-formaldehyde et ses utilisations
IT1312313B1 (it) * 1999-05-24 2002-04-15 Giorgio Mezzoli Acido tricloroacetico per la preparazione di soluzioni e/ocomposizioni per il trattamento di lesioni erosive e/o ulcerative.
IT1306171B1 (it) * 1999-07-21 2001-05-30 Wiktor Djaczenko Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
US6391860B1 (en) * 1999-09-09 2002-05-21 Mcgrath Patrick D. Method for preparation and use of paste formed by controlled reaction of sucralfate with hydrochloric acid
CN1273827A (zh) * 2000-04-24 2000-11-22 潘志荣 一种除癣灭痔杀菌液
WO2002102363A1 (en) 2001-06-20 2002-12-27 Lorus Therapeutics Inc. Biological response modifier composition and uses thereof
US7128903B2 (en) 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same

Also Published As

Publication number Publication date
AU2002341366A1 (en) 2003-04-14
EP1450771A2 (en) 2004-09-01
US7128903B2 (en) 2006-10-31
WO2003028623A2 (en) 2003-04-10
US20090123568A1 (en) 2009-05-14
US8658185B2 (en) 2014-02-25
EP1450771B1 (en) 2008-06-25
WO2003028623A3 (en) 2004-03-18
US20040234625A1 (en) 2004-11-25
US20030087960A1 (en) 2003-05-08
EP1450771A4 (en) 2005-04-27
DE60227278D1 (de) 2008-08-07
IL161177A0 (en) 2004-08-31
ATE399002T1 (de) 2008-07-15
ES2309205T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
DK1450771T3 (da) Farmaceutiske præparater til behandling af hudlæsioner og slimhinder og fremgangsmåder og kits til anvendelse heraf
JP5053096B2 (ja) ブロメラインからの創傷清拭組成物及びその製造方法
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DK1079806T3 (da) Præparater til påföringen af antiinflammatoriske, især antiseptiske midler og/eller midler, der fremmer helingen af sår, til de övre luftveje og/eller öret
NO312225B2 (no) Farmasoytiske preparater av fluoxetin
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
WO2002087563A3 (en) Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
ATE445389T1 (de) Liposomale glucocorticoide
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
SE9704833D0 (sv) New formulation
NO20004282L (no) Matriksproteinpreparater for sÕrheling
JPH0838173A (ja) 壊死組織を処理するための新規なプロテアーゼ
DK1251874T3 (da) Stabile farmaceutiske kompositioner og fremgangsmåde til fremstilling af disse, der omfatter et antibiotikum og et slimdrivende middel
WO2003082263A8 (en) Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
WO2002018363A3 (en) 3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
HUP0402645A2 (hu) Egy glitazont és egy 4-oxobutánsavat tartalmazó gyógyászati készítmény és ennek alkalmazása cukorbetegség kezelésére
ECSP003844A (es) Oxazolidinonas substituidas y su uso